The aim of this trial is to evaluate whether electronic reporting of PROMs through the DANBIO web application (webapp) is comparable to the outpatient touchscreen among patients with SLE.
The trial is a randomised, crossover, agreement study where 34 patients with SLE from the Department of Rheumatology at Aalborg University Hospital will be included and randomised in ratio 1:1 to:
* Group 1: PROMs are reported through the DANBIO webapp; thereafter, the touchscreen.
* Group 2: PROMs are reported through the touchscreen; thereafter, the DANBIO webapp.
There will be a wash-out period of 1-2 day between the two registrations to minimise carryover bias.
